Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Aluminum dihydride from E(IV) precursors (E = Si, Ge) and its bond-activation reactivities

Hemant Kumara, Steven P. Kelleya, Tanya Batrab, Selvarajan Nagendranb and Justin R. Walensky*a
aDepartment of Chemistry, University of Missouri, Columbia, Missouri 65211, USA. E-mail: walenskyj@missouri.edu
bDepartment of Chemistry, Indian Institute of Technology Delhi, Hauz Khas, New Delhi 110016, India

Received 25th February 2026 , Accepted 1st April 2026

First published on 8th April 2026


Abstract

A distinctive synthetic route has been demonstrated in which the aminotroponiminato (ATI)-stabilized aluminum dihydride complex [(ATI)AlH2] was prepared from a [(ATI)SiHCl2] precursor. [(ATI)AlH2] was also isolated from aluminum(III) dichloride [(ATI)AlCl2] via salt-metathesis reaction. Subsequent reaction with the ATIH ligand enabled the isolation of the N-tetracoordinated (ATI)Al(III)-complex via aluminum monohydride [(ATI)AlH(ATI)] intermediate. The dihydride compound was found to activate C[double bond, length as m-dash]S (in CS2) and P[double bond, length as m-dash]Se (in Ph3P[double bond, length as m-dash]Se) bonds yielding the aluminum(III) μ-sulphide and μ-selenide dimer [(ATI)Al(μ-S)]2 and [(ATI)Al(μ-Se)]2, respectively. All compounds were characterized using multinuclear NMR spectroscopy and single-crystal X-ray diffraction.


Introduction

Main-group metal hydrides constitute a diverse and fundamentally important class of compounds with broad relevance in catalysis, small-molecule activation, and energy storage.1–7 Among these, N-heterocyclic aluminum hydrides have emerged as a notable subclass, demonstrating utility in catalytic transformations and small-molecule activation.3,8–13 These compounds typically feature a terminal or bridging hydride bound to an aluminum centre that is stabilized by N-heterocyclic ligand frameworks such as amidinates, β-diketiminates, or pincer-type ligands.8,10–34 While most studies on aluminum hydrides have focused on systems supported by amidinate and β-diketiminate ligands, there remains significant scope to explore alternative ligands.

To the best of our knowledge, synthetic strategies that employ group-14 precursors (LEX3; E = Si or Ge) for the preparation of aluminum dihydrides have not yet been established. Our group has previously shown that treatment of H2Ge(3,5-(CF3)2C6H3) with [(C5Me5)2U(CH3)(I)], Scheme 1,35 can afford a compound with a uranium–germanium bond. To create other such starting materials, we targeted group 14 trihydride compounds of the form (ATI)E(H)3, (ATI) = iBu-substituted aminotroponiminate; E = Si, Ge. We recently reported the isolation of (ATI)-stabilized trichloro silane and germane compounds.36 While we now tried to convert these compounds to their respective trihydrides by adding LiAlH4, the result was an aluminum dihydride, [(ATI)AlH2].


image file: d6dt00474a-s1.tif
Scheme 1 Formation of a U–Ge bond through protonolysis of a U(IV)–methyl with a disubstituted germane.

In this context, ATI ligands present an attractive yet underexplored ligand for aluminum hydride stabilization. To date, only one example of an ATI-supported aluminum hydride, [(iPr)2ATI]AlH2, has been reported,37 but its reactivity remains unexplored. Aluminum dihydride complexes of the type LAlH2 (L = monoanionic ligand) are typically synthesized either via protonolysis of alane adducts (R3N·AlH3) with the corresponding ligand (LH) or via hydride substitution of LAlX2 (X = halide) precursors. Further, N-heterocyclic aluminum complexes containing heavier chalcogens and featuring Al2E2 cores (E = S, Se, Te) have generally been synthesized using elemental chalcogens or chalcogen-transfer reagents such as R3P[double bond, length as m-dash]E.32,38–43 Notably, in 2019 Cabrera and co-workers reported, [{MeLAl(μ-S)}2], containing a four-membered Al2S2 ring, through the activation of CS2 by MeLAlH2 (MeL = HC[(CMe)N(2,4,6-Me3C6H2)]2).44 This shows the ability of N-heterocyclic aluminum dihydride to activate CS2 which can be a useful model for CO2 reactivity or activation. Thus, in this contribution, apart from reporting the synthesis of ATI-stabilized aluminum dihydride [(ATI)AlH2] from a novel synthetic route starting from [(ATI)SiHCl2] 1, we also investigated the ability of the dihydride, 2, to activate C[double bond, length as m-dash]S and P[double bond, length as m-dash]Se bonds.

Results and discussion

Synthesis and spectra

Aminotroponimine (ATIH) was deprotonated with n-BuLi, followed by reaction with an equimolar amount of trichlorosilane (SiCl3H), yielding the ATI-stabilized dichlorosilane [(ATI)SiCl2H] 1 in 85% isolated yield (Scheme 2). Compound 1 is readily soluble in toluene, THF, and chloroform, but insoluble in pentane. The complex was characterized by multinuclear NMR spectroscopy, infrared (IR) spectroscopy, and single-crystal X-ray diffraction. The 1H NMR spectrum of 1 displayed the expected resonances. The methyl protons appeared as a doublet at δ = 0.82 ppm, while the methine and methylene protons were observed as a multiplet (δ = 2.06–2.00 ppm) and a doublet (δ = 3.61 ppm), respectively. The five protons of the seven-membered ATI backbone exhibited a triplet, doublet, and pseudo-triplet in a 1[thin space (1/6-em)]:[thin space (1/6-em)]2[thin space (1/6-em)]:[thin space (1/6-em)]2 intensity ratio at δ = 6.70, 6.56, and 6.30 ppm. The Si–H hydride resonance appeared as a singlet at δ = 7.05 ppm. The 13C NMR spectrum of compound 1 showed seven distinct signals: three in the aliphatic region corresponding to the isobutyl substituents and four in the aromatic region attributable to the seven-membered ATI-ring. In the 29Si NMR spectrum, compound 1 exhibits a doublet at δ = −88.0 ppm, which is shifted downfield relative to [(ATI)SiCl3] (δ = −95.5 ppm) and is consistent with closely related dichlorosilane species reported in the literature;45–49 for example, [Ph2P(NDipp)2]SiHCl2, Dipp = 2,6-iPr2C6H3, resonates at δ = −89.4 ppm.49 The IR spectrum of compound 1 displays two Si–H stretching bands at ν = 2357 and 2338 cm−1 consistent with the analogous systems such as [PhC{(NtBu)(NDipp)}]SiHCl2.50
image file: d6dt00474a-s2.tif
Scheme 2 Synthesis of ATI-stabilized dichlorosilane 1.

To synthesize N-heterocyclic silane [(ATI)SiH3], the reaction of compound 1 was carried out with LiAlH4, which led to the unusual reactivity and afforded [(ATI)AlH2], 2, as a product (with 68% yield) instead of [(ATI)SiH3]. Compound 2 is soluble in pentane, toluene, and THF. Similar reactions starting with [(ATI)SiCl3] or [(ATI)GeCl3] also afforded compound 2 with 80% yield (Scheme 3). Compound 2 was characterized using multinuclear NMR-spectroscopy, IR spectroscopy, and single-crystal X-ray diffraction techniques. The 1H NMR spectrum of compound 2 gave the anticipated results; the resonance of methyl protons appeared as a doublet (δ = 0.92 ppm). Methine and methylene protons appeared as a multiplet (δ = 2.13–2.19 ppm) and a doublet (δ = 3.00 ppm), respectively. The Al–H hydride appeared as a singlet (δ = 5.06 ppm). The five protons of the seven-membered ring appear as triplet, doublet, and pseudo triplet in a 1[thin space (1/6-em)]:[thin space (1/6-em)]2[thin space (1/6-em)]:[thin space (1/6-em)]2 intensity ratio (δ = 6.23, 6.36, and 6.76 ppm). As anticipated, in its 13C NMR spectrum, seven peaks were observed, in which three peaks appeared in the aliphatic region for the isobutyl groups and four peaks in the aromatic region corresponding to the seven-membered ATI-backbone ring. Compound 2 crystallized as a tetramer, but in solution, it is a monomer, confirmed by DOSY-NMR experiment (Fig. S9). In solution, a broad singlet is observed at 2.24 ppm in the 27Al NMR spectrum (Fig. S8), suggesting one type of Al(III)-centre, unlike the related compound [(Et3SiOAlH2)2AlH3]2, which has two-types of Al-centres in solution as well as in solid-state.51 The IR-band for the Al–H bond appears at 1960 (sharp band for terminal Al–H) and 1789 (broad band for bridging Al–H) cm−1, which is in good agreement with the related reported compound [(Et3SiOAlH2)2AlH3]2.51


image file: d6dt00474a-s3.tif
Scheme 3 Synthesis of ATI-stabilized Aluminium(III) dihydride 2.

After isolating compound 2 via the aforementioned synthetic route, the reaction between the aminotroponimine ligand (ATIH) and Et3N·AlH3 was attempted to prepare compound 2. However, this reaction did not yield the target product. Instead, it afforded an N-tetracoordinate Al(III) complex. To probe the mechanism of the formation of this N-tetracoordinate compound, ATIH was treated with Et3N·AlH3 in a 2[thin space (1/6-em)]:[thin space (1/6-em)]1 stoichiometric ratio affording the pentacoordinated Al(III)–monohydride [(ATI)AlH(ATI)] 3. Complex 3 eventually undergoes intramolecular hydride transfer from Al-centre to ATI-backbone to afford an N-tetracoordinate Al(III) complex 4 (Scheme 4). In this reaction, after 1 h, the products 3 and 4 were observed in 9[thin space (1/6-em)]:[thin space (1/6-em)]1 ratio (Fig. S20) and after the stirring of this reaction mixture in toluene for 12 h, compound 4 was isolated with 60% yield. This indicates that compound 3 is acting as an intermediate for the formation of compound 4. For the isolation of compound 3, the reaction of 2 with ATIH was also carried out to afford the desired product with 81% yield (Scheme 4). Compounds 3 and 4 are soluble in toluene and THF but insoluble in pentane. Compounds 3 and 4 were characterized by multinuclear NMR-spectroscopy and single-crystal X-ray diffraction techniques. In the 1H NMR spectrum of 3, the methyl protons appeared as a doublet at δ = 0.92 ppm, while the methine and methylene protons were observed as a multiplet (δ = 2.25–2.20 ppm) and a doublet (δ = 3.39 ppm), respectively. The five protons of the seven-membered ATI backbone exhibited a triplet, doublet, and pseudo-triplet in a 1[thin space (1/6-em)]:[thin space (1/6-em)]2[thin space (1/6-em)]:[thin space (1/6-em)]2 intensity ratio at δ = 6.22, 6.58, and 6.83 ppm. The 13C NMR spectrum of compound 3 showed seven distinct signals: three in the aliphatic region corresponding to the isobutyl substituents and four in the aromatic region attributable to the seven-membered ATI-ring. Compound 4 contains two ATI-ligand backbones which appear separately in the 1H NMR spectrum; the resonance of methyl protons of the isobutyl-groups appeared as a pseudo triplet (δ = 0.78 ppm) and a doublet (δ = 0.89 ppm). Methine protons appeared as two multiplets (δ = 1.97–2.07 and 2.09–2.19 ppm). The methylene protons corresponding to the iBu-groups of the non-aromatic and aromatic ligand backbone appear as two doublets (δ = 2.99 and 3.08 ppm) and one doublet (δ = 3.25 ppm), respectively. The five protons of the aromatic seven-membered ring appear as triplet, doublet, and pseudo triplet in a 1[thin space (1/6-em)]:[thin space (1/6-em)]2[thin space (1/6-em)]:[thin space (1/6-em)]2 intensity ratio (δ = 6.32, 6.66, and 6.80 ppm). The five protons of the non-aromatic seven-membered ring appear uniquely. The methylene protons of the non-aromatic seven-membered ring appeared as a triplet (δ = 2.76 ppm), the other four protons appear as a triplet, multiplets and doublet of doublets (δ = 4.76, 5.67–5.72, and 6.47 ppm). As compound 3 is asymmetric, the 13C NMR spectrum shows 20 distinct resonances.


image file: d6dt00474a-s4.tif
Scheme 4 Synthesis of compounds 3–5.

To isolate compound 2, starting from an Al(III) precursor, Al(III)–dichloride, the reaction of aminotroponimine ligand was carried out with n-BuLi followed by the addition of AlCl3 to afford ATI-stabilized aluminum dichloride, [(ATI)AlCl2], 5 (Scheme 4). Although, the ATI-ligand has been used to isolate Al(III)–dihydride and –dimethyl,37 compound 5 is the first example of ATI-ligand stabilized Al(III)–dihalide. Compound 5 is soluble in toluene, THF, and chloroform but insoluble in pentane. Compound 5 was characterized by multinuclear NMR spectroscopy and single-crystal X-ray diffraction techniques. In the 1H NMR spectrum of compound 5, the resonance of methyl protons appeared as a doublet (δ = 0.86 ppm). Methine and methylene protons appeared as a multiplet (δ = 2.25–2.10 ppm) and a doublet (δ = 3.16 ppm), respectively. The five protons of the seven-membered ring appear as a triplet, doublet, and pseudo triplet in a 1[thin space (1/6-em)]:[thin space (1/6-em)]2[thin space (1/6-em)]:[thin space (1/6-em)]2 intensity ratio (δ = 6.30, 6.50, and 6.73 ppm). As anticipated, seven peaks were observed in the 13C NMR spectrum, in which three peaks appeared in the aliphatic region for the isobutyl groups and four peaks in the aromatic region corresponding to the seven-membered ATI-backbone ring. After isolating the desired Al(III)–dichloride 5, its reaction with LiAlH4 was performed in THF to afford compound 2 in 76% yield (Scheme 4 and Fig. S21).

To explore the reactivities of Al(III)–dihydride, 2, the activation of the C[double bond, length as m-dash]S bond of CS2 was achieved by the reaction of compound 2 with CS2 to afford ATI-stabilized Al(III)–sulfide dimer [(ATI)Al(μ-S)]2 6 as a product, with 65% yield. The activation of CS2 by MeLAlH2 to afford aluminum(III) sulfide-bridged dimer [{MeLAl(μ-S)}2]44 proceeds through a detectable aluminum thioformate intermediate with the removal of H2CS in the following step. Although they did not observe thioformaldehyde, they observed 1,3,5-trithianethe (at 4.17 ppm), the primary decomposition product of thioformaldehyde. In contrast, no such thioformate intermediate or 1,3,5-trithianethe was observed in the reaction of compound 2 with CS2, as evidenced by the absence of any diagnostic thioformate or 1,3,5-trithianethe resonance in the 1H NMR spectrum. However, H2 was detected in the 1H NMR spectrum (Fig. S24). A similar reaction of compound 2 with CO2 did not yield the oxo-analogue of compound 6 but instead gave a mixture of products. Unlike MeLAlH2, Compound 6 can also be isolated from the reaction of compound 2 with S8, with 85% yield. This indicates that aluminum hydride bond activations can occur via different mechanisms. The reaction of compound 4 with S8 also affords compound 6 as a product (Scheme 5) (with unidentified side products), confirmed by 1H NMR spectroscopy and SC-XRD analysis. The reaction of compound 4 with CS2 gave a mixture of products.


image file: d6dt00474a-s5.tif
Scheme 5 Synthesis of [(ATI)Al(μ-S)]2 6.

In an effort to obtain the selenide analogue of compound 6, compounds 2 and 4 were reacted with elemental selenium; however, no reaction occurred even upon heating up to 80 °C. Alternatively, activation of the P[double bond, length as m-dash]Se bond in triphenylphosphine selenide (SePPh3) by compound 2 afforded the Al(III) selenide dimer [(ATI)Al(μ-Se)]2 7 in 87% yield (Scheme 6). In contrast to the conversion of compound 4 to compound 6 shown in Scheme 5, analogous reactions of compound 4 with either selenium powder or SePPh3 showed no reaction. Compounds 6 and 7 represent examples of N-heterocyclic Al(III)–chalcogenide species featuring an Al2E2 ring motif. Both compounds are soluble in THF but insoluble in toluene and pentane. Compounds 6 and 7 were characterized by multinuclear NMR spectroscopy and single-crystal X-ray diffraction. The 1H NMR and 13C NMR spectra of compounds 6 and 7 gave similar and anticipated results. For compound 6, the resonance of methyl protons appeared as a doublet (δ = 1.08 ppm). Methine and methylene protons appeared as a multiplet (δ = 2.45–2.40 ppm) and a doublet (δ = 3.59 ppm), respectively. The five protons of the seven-membered ring appear as triplet, doublet, and pseudo triplet in a 1[thin space (1/6-em)]:[thin space (1/6-em)]2[thin space (1/6-em)]:[thin space (1/6-em)]2 intensity ratio (δ = 6.65, 6.92, and 7.25 ppm). As anticipated, in its 13C NMR spectrum, seven peaks were observed, in which three peaks appeared in the aliphatic region for the isobutyl groups and four peaks in the aromatic region corresponding to the seven-membered ATI-backbone ring.


image file: d6dt00474a-s6.tif
Scheme 6 Synthesis of [(ATI)Al(μ-Se)]2 7.

X-ray crystal structures of compounds 1–7

Single crystals of compounds 1–7, suitable for single-crystal X-ray diffraction (SCXRD) studies, were grown according to the procedures described in the Experimental section. Compound 1 crystallized in the monoclinic P21/n space group. The Si(IV)-centre in compound 1 possesses a distorted trigonal bipyramidal geometry (τ5 = 0.75) (The τ5 is defined as: τ5 = (βα)/60°. α and β refer to the two largest θ bond angles in a five-coordinate complex. In an ideal square pyramidal structure (τ5 = 0), α = β = 180°; while in an ideal trigonal bipyramidal structure (τ5 = 1), α = 120° and β = 180°),52 having two N-atoms, two Cl-atoms, and one H-atom attached to it (Fig. 1). The Si–Cl bond lengths (Si1–Cl1 2.2202(6) and Si1–Cl2 2.1184(7)) in compound 1 are similar to those of related compounds;45–49 for example, in β-diketiminate stabilized dichlorosilane [(L)SiHCl2] (L = Dipp-N[double bond, length as m-dash]CH–CH[double bond, length as m-dash]CH–N-Dipp) the Si–Cl bond lengths are 2.192(1) and 2.091(1) Å.46 The Si1–Cl1 bond at axial position is longer than that of the Si1–Cl2 at equatorial position as Si1–Cl1 experience greater repulsion from the three equatorial bonds.
image file: d6dt00474a-f1.tif
Fig. 1 Molecular structure of compound 1: all hydrogen atoms except hydride ligand are omitted for clarity, and thermal ellipsoids are drawn at the 50% probability level. Selected bond lengths (Å) and angles (°): Si1–N1 1.793(1), Si1–N2 1.849(1), Si1–Cl1 2.2202(6), Si1–Cl2 2.1184(7), Si1–H1 1.58(3); N1–Si1–N2 84.27(6), N1–Si1–Cl1 95.54(5), N1–Si1–H1 131.00(1), Cl1–Si1–H1 86.00(1), N2–Si1–Cl1 176.15(5).

Compound 2 crystallized as a tetramer, in the monoclinic P21/c space group. In the molecular structure of compound 2, two types of Al-centres are present; two (Al1 and Al1*) are pentacoordinate, having distorted square pyramidal (τ5 = 0.16) geometry, and the other two (Al2 and Al2*) are hexacoordinated, having distorted octahedral geometry (Fig. 2). All the Al–N bond lengths are similar, indicating the same oxidation state (+3) of all four Al-centres. The molecular structure of compound 2 contains two types of Al–H bonds: terminal and bridging. The bridging Al–H bond length (1.73(2) Å) is larger than the terminal one (1.54(2) Å) and are in good agreement with the related tetrameric-core in [(Et3SiOAlH2)2AlH3]2 and [H2Al(O-C5H9)]6[H(Cl)Al(O-C5H9)]2.51,53 The molecular structure of compound 2 is the unique example of a tetrameric N-heterocyclic alane.


image file: d6dt00474a-f2.tif
Fig. 2 Molecular structure of compound 2: all hydrogen atoms except hydride ligands are omitted for clarity, and thermal ellipsoids are drawn at the 50% probability level. Selected bond lengths (Å) and angles (°): Al1–N1 1.916(2), Al1–N2 1.947(1), Al1–H1 1.54(2), Al1–H2 1.73(2), Al2–H2 1.74(2), Al2–N3 1.915(1), Al2–N4 1.924(2), Al2–H3 1.71(2); N1–Al1–N2 81.31(7), N3–Al1–N4 82.61(6), N1–Al1–H2 85.8(6), N2–Al1–H1 85.8(6), Al2–H3–Al2* 101(1).

Compound 3 crystallized in the triclinic P[1 with combining macron] space group. In the molecular structure of the compound 3, the Al-centre possess a distorted trigonal pyramidal geometry (τ5 = 0.72), having four N-atoms and one H-atom attached to it (Fig. 3). As expected, the Al1–N3 and Al1–N2 bonds at the axial positions in the trigonal bipyramidal geometry are longer than the Al1–N1 and Al1–N4 bonds at the equatorial positions, as the bonds present at axial positions experience more repulsion than those present at equatorial positions in the trigonal bipyramidal geometry. The Al–H bond distance (1.62(8) Å) in 3 is between the terminal and the bridging Al–H bond distances in 2, probably due to the difference in the coordination environment.


image file: d6dt00474a-f3.tif
Fig. 3 Molecular structure of compound 3: all hydrogen atoms except hydride ligand are omitted for clarity, and thermal ellipsoids are drawn at the 50% probability level. Selected bond lengths (Å) and angles (°): Al1–N1 1.942(5), Al1–N2 1.978(6), Al1–N3 1.963(6), Al1–N4 1.940(5), Al1–H1 1.62(8); N1–Al1–N2 78.8(2), N3–Al1–N4 79.8(2), N1–Al1–H1 129.00(2), N2–Al1–N3 172.0(3).

Compounds 4 and 5 crystallized in the monoclinic P21/n space group. The Al(III)-centres, in compounds 4 and 5, possess a distorted tetrahedral geometry (4: τ4 = 0.83, 5: τ4 = 0.85) (The τ4 is defined as: τ4 = [360° − (α + β)]/141°. α and β refer to the two largest θ bond angles in a four-coordinate complex. In an ideal tetrahedral structure (τ4 = 1), α = β = 109.5°, while in an ideal square planar structure (τ4 = 0), α = β = 180°) (Fig. 4).54 In the molecular structure of compound 4, one of the rings has the typical geometry of a planar, aromatic aminotroponiminate-backbone and the other one is non-planar. The N3–C1 (1.404(2) Å) and N4–C5 (1.402(2) Å) bond lengths are longer than that of N1–C7 (1.350(2) Å) and N2–C6 (1.346(2) Å). In N3–C1 and N4–C5 bonds of dianionic non-aromatic ligand, there is no imine character present, while in N1–C7 and N2–C6, which are part of a monoanionic aromatic ATI-ligand, there is an imine C[double bond, length as m-dash]N character present. As a result, the Al1–N1 (1.863(2) Å) and Al2–N2 (1.863(2) Å) bond lengths are also longer than the Al1–N3 (1.835(2) Å) and Al1–N4 (1.817(2) Å) bond distances, which are consistent with the Al–N single bond length. The C2–C3 bond length (1.489(3) Å) is longer than the C1–C2 bond length (1.359(3) Å), indicating single-bond character for the C2–C3 bond, with a sp3-C3 carbon. In the molecular structure of compound 5, the bond lengths Al1–Cl1 (2.127(5) Å) and Al1–Cl2 (2.124(6) Å) are in good agreement with related compounds;55–61 for example, β-diketiminate ligand stabilized Al(III)–dichloride [HC{C(Me)N(C6H3-2,6-iPr2)}2AlCl2] has Al–Cl bond lengths of 2.1344(4) and 2.1185(4) Å.55


image file: d6dt00474a-f4.tif
Fig. 4 Molecular structure of compound 4: all hydrogen atoms are omitted for clarity (except methylene hydrogens in the backbone), and thermal ellipsoids are drawn at the 50% probability level. Selected bond lengths (Å) and angles (°): Al1–N1 1.876(2), Al1–N2 1.863(2), Al1–N3 1.835(2), Al1–N4 1.817(2), C1–C2 1.359(3), C2–C3 1.489(3), N3–C1 1.404(2), N4–C5 1.402(2), N1–C7 1.350(2), N2–C6 1.346(2); N1–Al1–N2 85.06(7), N3–Al1–N4 91.11(7), N1–Al1–N3 121.86(7), N2–Al1–N4 121.82(7), C1–C2–C3 123.8(2), C2–C3–C4 117.6(2). Molecular structure of compound 5: all hydrogen atoms are omitted for clarity, and thermal ellipsoids are drawn at the 50% probability level. Selected bond lengths (Å) and angles (°): Al1–N1 1.850(1), Al1–N2 1.846(1), Al1–Cl1 2.127(5), Al1–Cl2 2.124(6); N1–Al1–N2 87.05(6), N1–Al1–Cl1 119.41(4), N1–Al1–Cl2 110.78(4), Cl1–Al1–Cl2 107.97(2).

The two isostructural compounds 6 and 7 crystallize in the orthorhombic Pbca space group, each with a planar Al2E2 (E = S, Se) core (Fig. 5). In compounds 6 and 7, the Al-centres show distorted tetrahedral geometry (6: τ4 = 0.82, 7: τ4 = 0.83). The Al–E (E = S, Se) bond length increased as the size of the chalcogen atom increased; the Al1–S1 bond length (2.228(1) Å) in compound 6, is slightly shorter than the Al1–Se1 bond length (2.350(1) Å) in compound 6. Due to the chalcogen ionic radii, the S1–Al1–S1* bond angle (101.53(4)°), in compound 6, is also smaller than the Se1–Al1–Se1* bond angle (102.24(4)°) in compound 7. The Al–E (E = S, Se) bond distances and E–Al–E (E = S, Se) bond angles in compound 6 and 7 are similar to the related N-heterocyclic-Al2E2 (E = S, Se) ring containing compounds (for E = S: bond length range is 2.185(2)–2.245(1) Å and bond angle range is 96.5(1)–102.47(3)°; for E = Se: bond length range is 2.314(1)–2.381(1) Å) and bond angle range is 97.5(1)–104.5(3)°.32,38–43 The difference in the E–Al–E bond angle range depends on the ligand backbone bulkiness.


image file: d6dt00474a-f5.tif
Fig. 5 Molecular structure of compound 6: all hydrogen atoms are omitted for clarity, and thermal ellipsoids are drawn at the 50% probability level. Selected bond lengths (Å) and angles (°): Al1–N1 1.870(2), Al1–N2 1.865(2), Al1–S1 2.228(1), Al1–S1* 2.223(1); N1–Al1–N2 84.6(1), N1–Al1–S1 120.78(8), N2–Al1–S1* 121.93(8), Al1–S1–Al1* 78.47(4), S1–Al1–S1* 101.53(4). Molecular structure of compound 7: all hydrogen atoms are omitted for clarity, and thermal ellipsoids are drawn at the 50% probability level. Selected bond lengths (Å) and angles (°): Al1–N1 1.875(3), Al1–N2 1.875(3), Al1–Se1 2.350(1), Al1–Se2* 2.358(1); N1–Al1–N2 85.0(1), N1–Al1–Se1 114.74(9), N2–Al1–Se1* 113.16(9), Al1–Se1–Al1* 77.76(4), Se1–Al1–Se1* 102.24(4).

Conclusions

In summary, we report a previously unprecedented synthetic approach that enables the isolation of the ATI-stabilized aluminum dihydride complex [(ATI)AlH2], 2, from Si(IV)/Ge(IV) precursors. The reactivity of compound 2 has been further demonstrated through the activation of C[double bond, length as m-dash]S bond in CS2 and P[double bond, length as m-dash]Se bond in Ph3PSe, leading to the formation of the aluminum(III) μ-sulphide dimer [(ATI)Al(μ-S)]2 6, and the aluminum(III) μ-selenide dimer [(ATI)Al(μ-Se)]2 7, respectively. Ongoing studies are focused on elucidating the broader reactivity and potential applications of compounds 1–7.

Experimental section

General considerations

All syntheses were carried out under an N2 atmosphere using glovebox and Schlenk techniques unless otherwise stated. All solvents used were dried by passing through a solvent purification system (MBraun, USA). Benzene-d6 (Cambridge Isotope Laboratories) was degassed by three freeze–pump–thaw cycles and stored over a potassium mirror. ATIH ligand was synthesized as reported.62 All 1H and 13C{1H} spectra were taken on 300, 400 or 500 MHz Bruker spectrometers. All NMR chemical shifts are reported in ppm. 1H NMR chemical shifts were referenced internally to the residual solvent peak of C6D6 at 7.16 ppm. 13C NMR chemical shifts were referenced internally to C6D6 at 128.06 ppm. For 29Si and 27Al NMR, Et3SiH and AlMe3 have been used as an external reference, respectively. IR spectra were taken on a Nicolet Summit Pro FTIR spectrometer in transmission mode. DOSY spectra were recorded using Bruker's “ledbpgp2s” program. The gradient strength varied from 5% to 95%.

Synthesis of [(ATI)SiHCl2], 1

To a solution of aminotroponimine (ATIH) (0.20 g, 0.86 mmol) in THF (20 mL), n-BuLi (2.5 M solution in hexane) (0.38 mL, 0.95 mmol) was added at −78 °C. After 30 minutes, the reaction mixture was slowly brought to room temperature and stirred for 3 h. This mixture was taken to −78 °C, and SiCl3H (0.096 mL, 0.946 mmol) was added. After the addition of SiCl3H was complete, the reaction mixture was brought to room temperature and stirred for 16 h. After that, THF was removed under vacuum, and the reaction mixture was extracted using toluene. The mixture was then filtered through a fine-porosity frit. Removing all volatiles from the filtrate under reduced pressure gave an orange-yellow solid. It was washed with pentane (2 × 5 mL) and dried under a vacuum to afford an analytically pure sample of compound 1 as a yellow solid. Single crystals suitable for X-ray diffraction studies were obtained from a saturated solution of compound 1 in toluene at −40 °C. Yield: 85%. 1H NMR (400 MHz, C6D6): δ 7.05 (s, 1H, SiH), 6.70 (t, 3JH–H = 9.5 Hz, 2H, ArH), 6.56 (d, 3JH–H = 11.1 Hz, 2H, ArH), 6.30 (t, 3JH–H = 9.4 Hz, 1H, ArH), 3.61 (d, 3JH–H = 7.4 Hz, 4H, CH2), 2.06–2.00 (m, 2H, (CH3)2CH), 0.82 (d, 3JH–H = 6.7 Hz, 12H, CH3). 29Si{1H} NMR (79.5 MHz, C6D6): δ −88.2 (s, Si–H). 29Si NMR (60 MHz, C6D6): δ −88.0 (d, 2JSi–H = 347.0 Hz, Si–H). 13C{1H} NMR (101 MHz, C6D6): δ 155.2, 137.8, 125.3, 118.2, 52.2, 27.1, 20.8 ppm. IR: ν(Si–H) = 2357 and 2338 cm−1.

Synthesis of [(ATI)AlH2], 2

To the solution of compound 1 (0.20 g, 0.60 mmol) in diethyl ether (10 mL), LiAlH4 (0.07 g, 1.8 mmol) was added at −30 °C, and the reaction mixture was allowed to be stirred for 2 h at room temperature. After that, the reaction mixture was filtered through a fine-porosity frit. The solvent was removed under reduced pressure, and the remaining solid was extracted in toluene. This solution was concentrated and kept at −30 °C in the freezer to afford analytically pure, yellow-colored crystals of compound 2. Yield: 68%. 1H NMR (400 MHz, C6D6): δ 6.76 (t, 3JH–H = 10.2 Hz, 2H, ArH), 6.36 (d, 3JH–H = 11.1 Hz, 2H, ArH), 6.23 (t, 3JH–H = 9.3 Hz, 1H, ArH), 5.06 (s, 2H, AlH), 3.00 (d, 3JH–H = 6.9 Hz, 4H, CH2), 2.19–2.13 (m, 2H, (CH3)2CH), 0.92 (d, 3JH–H = 6.5 Hz, 12H, CH3).13C NMR (101 MHz, C6D6): δ 162.9, 136.7, 120.1, 114.4, 55.4, 28.6, 21.5. 27Al NMR (130.3 MHz, C6D6, 298 K): 2.24 (s, broad). IR: ν(Al–H) = 1760 (sharp, Al–H, terminal), 1789 (broad, Al–H, bridging) cm−1.

Synthesis of [(ATI)AlH(ATI)], 3

To a solution of 2 (0.030 g, 0.11 mmol) in toluene (5 mL), toluene (2 mL) solution of ATIH (0.0267 g, 0.11 mmol) was added, and the reaction mixture was stirred for 0.5 h. After that, the solvent was removed under reduced pressure to obtain a yellow solid compound. This solid was washed with pentane (2 × 2 mL) to afford analytically pure yellow compound 3. Single crystals suitable for X-ray diffraction studies were obtained from a saturated solution of compound 3 in toluene at −30 °C. Yield: 81%. 1H NMR (500 MHz, C6D6): δ 6.83 (t, 3JH–H = 10.1 Hz, 2H, ArH), 6.58 (d, 3JH–H = 11.3 Hz, 2H, ArH), 6.22 (t, 3JH–H = 9.1 Hz, 1H, ArH), 5.32 (s, very broad, Al–H), 3.39 (d, 3JH–H = 7.0 Hz, 4H, CH2), 2.25–2.2 (m, 2H, (CH3)2CH), 0.92 (d, 3JH–H = 6.6 Hz, 12H, CH3) ppm.13C NMR (125 MHz, C6D6): δ 161.4, 135.3, 118.2, 113.9, 54.2, 26.9, 21.4. IR: ν(Al–H) = 1705 (weak, broad, Al–H) cm−1.

Synthesis of [(ATI)Al(ATIH)], 4

To a solution of ATIH (0.098 g, 0.42 mmol) in toluene (5 mL), toluene (2 mL) solution of Et3N·AlH3 (0.0276 g, 0.21 mmol) was added, and the reaction mixture was stirred for 1 h and after evaporation of toluene ∼91% of 3 and ∼9% of 4 was observed in 1H NMR spectrum. This solid reaction mixture was further dissolved in toluene, giving a yellowish-orange solution, and stirred for 12 h to give a reddish-yellow solution. After that, the solvent was removed under reduced pressure to obtain a reddish-yellow solid compound. This solid was washed with pentane (3 × 2 mL) to afford analytically pure reddish-yellow compound 4. Single crystals suitable for X-ray diffraction studies were obtained from a saturated solution of compound 4 in toluene at −30 °C. Yield: 60%. 1H NMR (400 MHz, C6D6): δ 6.80 (t, 3JH–H = 9.5 Hz, 2H, ArH), 6.66 (d, 3JH–H = 11.3 Hz, 2H, ArH), 6.47 (dd, 3JH–H = 9.2, 6.5 Hz, 1H, n-ArH), 6.32 (t, 3JH–H = 9.2 Hz, 1H, ArH), 5.72–5.67 (m, 2H, n-ArH), 4.76 (t, 3JH–H = 7.3 Hz, 1H, n-ArH), 3.25 (d, 3JH–H = 6.9 Hz, 4H, (i-Bu)CH2), 3.08 (d, 3JH–H = 6.5 Hz, 2H, (i-Bu)CH2), 2.99 (d, 3JH–H = 6.3 Hz, 2H, (i-Bu)CH2), 2.76 (t, 3JH–H = 6.9 Hz, 2H, -ArCH2), 2.19–2.09 (m, 2H, (i-Bu)CH), 2.07–1.97 (m, 2H, (i-Bu)CH), 0.91 (d, 3JH–H = 6.6 Hz, 6H, CH3), 0.89 (d, 3JH–H = 6.6 Hz, 6H, CH3), 0.78 (t, 3JH–H = 6.3 Hz, 12H, CH3) ppm. 13C{1H} NMR (101 MHz, C6D6): 13C NMR (101 MHz, C6D6): δ 161.2, 154.2, 149.2, 136.7, 126.8, 122.5, 116.2, 115.8, 99.2, 90.2, 56.1, 55.3, 55.1, 28.3, 27.8, 27.1, 26.7, 22.0, 21.9, 21.2 ppm.

Synthesis of [(ATI)AlCl2], 5

To a solution of aminotroponimine (ATIH) (0.20 g, 0.86 mmol) in toluene (20 mL), n-BuLi (2.5 M solution in hexane) (0.38 mL, 0.95 mmol) was added at −30 °C and stirred for 3 h at room temperature. To this reaction mixture, toluene suspension of AlCl3 (0.114 g, 0.86 mmol) was added at −30 °C, and the reaction mixture was stirred at room temperature for 2 h. After the reaction time, the yellow-coloured toluene solution was carefully transferred (leaving the settled oily side product) to a fine-porosity frit and filtered. Removing all volatiles from the filtrate under reduced pressure gave a yellow solid. It was washed with pentane (3 × 5 mL) and dried under a vacuum to afford an analytically pure sample of compound 5 as a yellow solid. Single crystals suitable for X-ray diffraction studies were obtained from a saturated solution of compound 5 in toluene at −30 °C. Yield: 62%. 1H NMR (400 MHz, C6D6): δ 6.73 (t, 3JH–H = 10.2 Hz, 2H, ArH), 6.50 (d, 3JH–H = 11.2 Hz, 2H, ArH), 6.30 (t, 3JH–H = 9.3 Hz, 1H, ArH), 3.16 (d, 3JH–H = 7.1 Hz, 4H, CH2), 2.25–2.10 (m, 2H, (CH3)2CH), 0.86 (d, 3JH–H = 6.6 Hz, 12H, CH3). 13C NMR (125 MHz, C6D6): δ 161.1, 137.1, 123.3, 116.26, 54.3, 28.1, 21.2.

Synthesis of [(ATI)Al(μ-S)]2, 6

To a solution of compound 2 (0.10, 0.38 mmol) in toluene (5 mL), CS2 (0.028 mL, 0.58 mmol) was added, and the reaction mixture was stirred for 2 h. After the reaction time, a yellow-coloured precipitate formed. The reaction mixture was filtered through a fine-porosity frit, and the residue was washed with toluene (2 × 2 mL). The residue was collected, dissolved in THF to form a saturated solution, and stored at −30 °C to afford analytically pure, yellow-colored crystals of compound 6. Yield: 65%. 1H NMR (500 MHz, CDCl3): δ 7.25 (t, 3JH–H = 10.2 Hz, 4H, ArH), 6.92 (d, 3JH–H = 11.3 Hz, 4H, ArH), 6.65 (t, 3JH–H = 9.4 Hz, 2H, ArH), 3.59 (d, 3JH–H = 7.3 Hz, 8H, CH2), 2.45–2.40 (m, 4H, (CH3)2CH), 1.08 (d, 3JH–H = 6.6 Hz, 24H, CH3). 13C NMR (101 MHz, CDCl3): δ 161.2, 136.5, 121.8, 115.3, 54.0, 27.8, 21.7.

Synthesis of [(ATI)Al(μ-Se)]2, 7

To a solution of compound 2 (0.10, 0.38 mmol) in toluene (5 mL), SePPh3 (0.13 g, 0.38 mmol) was added, and the reaction mixture was stirred for 2 h. After the reaction time, a yellow-coloured precipitate formed. The reaction mixture was filtered through a fine-porosity frit, and the residue was washed with toluene (2 × 2 mL). The residue was then collected, and the residual solvent was removed under reduced pressure to afford a yellow-colored analytically pure compound 7. Single crystals suitable for X-ray diffraction studies were obtained from a saturated solution of compound 7 in THF at −30 °C. Yield: 87%. 1H NMR (500 MHz, CDCl3): δ 7.25 (t, 3JH–H = 10.2 Hz, 4H, ArH), 6.91 (d, 3JH–H = 11.3 Hz, 4H, ArH), 6.63 (t, 3JH–H = 9.3 Hz, 2H, ArH), 3.61 (d, 3JH–H = 7.2 Hz, 8H, CH2), 2.53–2.43 (m, 4H, (CH3)2CH), 1.09 (d, 3JH–H = 6.6 Hz, 24H, CH3). 13C NMR (101 MHz, CDCl3): δ 161.0, 136.4, 121.9, 115.6, 53.9, 27.9, 21.8 ppm. 77Se NMR: Not observed (range attempted: 1000 to −880 ppm).

Conflicts of interest

There are no conflicts to declare.

Data availability

The data supporting this article have been included as part of the supplementary information (SI). Supplementary information: NMR spectra and DOSY NMR experiment and IR spectra. See DOI: https://doi.org/10.1039/d6dt00474a.

CCDC 2532228–2532233, 2538185 (1–7) contain the supplementary crystallographic data for this paper.63a–g

Acknowledgements

J. R. W. gratefully acknowledges the Department of Energy, Office of Basic Energy Sciences, Heavy Element Program under Award DE-SC0021273. H. K. gratefully acknowledges the MU College of Arts & Science and Department of Chemistry for postdoctoral funding. S. N. thanks the SERB, Department of Science and Technology (DST), New Delhi, India, for funding (CRG/2022/005756).

References

  1. W. Grochala and P. P. Edwards, Chem. Rev., 2004, 104, 1283–1316 CrossRef CAS PubMed.
  2. S. Harder, Chem. Commun., 2012, 48, 11165 RSC.
  3. M. M. D. Roy, A. A. Omaña, A. S. S. Wilson, M. S. Hill, S. Aldridge and E. Rivard, Chem. Rev., 2021, 121, 12784–12965 CrossRef CAS PubMed.
  4. S. Aldridge and A. J. Downs, Chem. Rev., 2001, 101, 3305–3366 CrossRef CAS PubMed.
  5. T. He, H. Cao and P. Chen, Adv. Mater., 2019, 31, 1902757 CrossRef CAS PubMed.
  6. S. Goswami, P. Mandal, S. Sarkar, M. Mukherjee, S. Pal, D. Mallick and D. Mukherjee, Dalton Trans., 2024, 53, 1346–1354 RSC.
  7. C. Mandal, A. Kundu, S. Das, D. Adhikari and D. Mukherjee, Chem. – Eur. J., 2023, 29, e202301119 CrossRef CAS PubMed.
  8. Z. Yang, M. Zhong, X. Ma, K. Nijesh, S. De, P. Parameswaran and H. W. Roesky, J. Am. Chem. Soc., 2016, 138, 2548–2551 CrossRef CAS PubMed.
  9. C.-C. Chia, Y.-C. Teo, N. Cham, S. Y.-F. Ho, Z.-H. Ng, H.-M. Toh, N. Mézailles and C.-W. So, Inorg. Chem., 2021, 60, 4569–4577 CrossRef CAS.
  10. (a) Z. Pang, X. Ma, W. Yan, X. Yang, C. Ni, Y. Chen, P. Wu and Z. Yang, Inorg. Chem. Front., 2025, 12, 2772–2782 RSC; (b) M. De Vere-Tucker, I. Squire, M. Tritto, R. Anandkar, T. Syeda, D. Uthayan, G. Aguila, L. Silva de Moraes and C. Bakewell, Dalton Trans., 2026, 55, 4977–4987,  10.1039/D6DT00276E.
  11. K. Hobson, C. J. Carmalt and C. Bakewell, Inorg. Chem., 2021, 60, 10958–10969 CrossRef CAS PubMed.
  12. T. W. Myers and L. A. Berben, J. Am. Chem. Soc., 2013, 135, 9988–9990 CrossRef CAS PubMed.
  13. R. L. Falconer, G. S. Nichol and M. J. Cowley, Inorg. Chem., 2019, 58, 11439–11448 CrossRef CAS PubMed.
  14. Y.-L. Lien, Y.-C. Chang, N.-T. Chuang, A. Datta, S.-J. Chen, C.-H. Hu, W.-Y. Huang, C.-H. Lin and J.-H. Huang, Inorg. Chem., 2010, 49, 136–143 CrossRef CAS PubMed.
  15. T. W. Myers and L. A. Berben, Chem. Sci., 2014, 5, 2771–2777 RSC.
  16. P.-Y. Lee and L.-C. Liang, Inorg. Chem., 2009, 48, 5480–5487 CrossRef CAS PubMed.
  17. B. Luo, B. E. Kucera and W. L. Gladfelter, Dalton Trans., 2006, 4491 RSC.
  18. A. H. Cowley, F. P. Gabbaï, H. S. Isom and A. Decken, J. Organomet. Chem., 1995, 500, 81–88 CrossRef CAS.
  19. J.-C. Chang, C.-H. Hung and J.-H. Huang, Organometallics, 2001, 20, 4445–4447 CrossRef CAS.
  20. T. S. Koptseva, E. V. Baranov, S. Yu. Ketkov and I. L. Fedushkin, Inorg. Chem. Front., 2026, 13, 3070–3078 RSC.
  21. C. Mandal, A. Kundu, S. Panda and D. Mukherjee, Chem. Commun., 2026, 62, 869–873 RSC.
  22. M. L. Cole, A. J. Davies, C. Jones, P. C. Junk, A. I. McKay and A. Stasch, Z. Anorg. Allg. Chem., 2015, 641, 2233–2244 CrossRef CAS.
  23. S. González-Gallardo, V. Jancik, R. Cea-Olivares, R. A. Toscano and M. Moya-Cabrera, Angew. Chem., Int. Ed., 2007, 46, 2895–2898 CrossRef PubMed.
  24. C. Sindlinger, S. Lawrence, D. Cordes, A. Slawin and A. Stasch, Inorganics, 2017, 5, 29 CrossRef.
  25. M. L. Cole, C. Jones, P. C. Junk, M. Kloth and A. Stasch, Chem. – Eur. J., 2005, 11, 4482–4491 CrossRef CAS PubMed.
  26. C. G. Gianopoulos, K. Kirschbaum and M. R. Mason, Organometallics, 2014, 33, 4503–4511 CrossRef CAS.
  27. X. Wang, F. Rüttger, A. Krawczuk, R. Herbst-Irmer and D. Stalke, Eur. J. Inorg. Chem., 2024, 27, e202300629 CrossRef CAS.
  28. W. Uhl and B. Jana, Chem. – Eur. J., 2008, 14, 3067–3071 CrossRef CAS PubMed.
  29. N. Kuhn, S. Fuchs and M. Steimann, Z. Anorg. Allg. Chem., 2000, 626, 1387–1392 CrossRef CAS.
  30. N. Sarkar, S. Bera and S. Nembenna, J. Org. Chem., 2020, 85, 4999–5009 CrossRef CAS PubMed.
  31. A. E. Nako, S. J. Gates, A. J. P. White and M. R. Crimmin, Dalton Trans., 2013, 42, 15199 RSC.
  32. V. Jancik, M. M. Moya Cabrera, H. W. Roesky, R. Herbst-Irmer, D. Neculai, A. M. Neculai, M. Noltemeyer and H. Schmidt, Eur. J. Inorg. Chem., 2004, 2004, 3508–3512 CrossRef.
  33. Y. Yang, H. Li, C. Wang and H. W. Roesky, Inorg. Chem., 2012, 51, 2204–2211 CrossRef CAS PubMed.
  34. S. Ito, K. Tanaka and Y. Chujo, Inorganics, 2019, 7, 100 CrossRef CAS.
  35. M. L. Tarlton, S. P. Kelley and J. R. Walensky, Acta Crystallogr., Sect. E: Crystallogr. Commun., 2021, 77, 1258–1262 CrossRef CAS PubMed.
  36. H. Kumar, S. P. Kelley, T. Batra, S. Nagendran and J. R. Walensky, Z. Anorg. Allg. Chem., 2026, e202500231 CrossRef CAS.
  37. H. V. R. Dias, W. Jin and R. E. Ratcliff, Inorg. Chem., 1995, 34, 6100–6105 CrossRef CAS.
  38. M. Zhong, Y. Liu, X. Liu, X. Ma and Z. Yang, Inorg. Chim. Acta, 2017, 464, 182–185 CrossRef CAS.
  39. C. Cui, H. W. Roesky, M. Noltemeyer and H.-G. Schmidt, Organometallics, 1999, 18, 5120–5123 CrossRef CAS.
  40. Y. Peng, H. Hao, V. Jancik, H. W. Roesky, R. Herbst-Irmer and J. Magull, Dalton Trans., 2004, 3548 RSC.
  41. S. González-Gallardo, A. S. Cruz-Zavala, V. Jancik, F. Cortés-Guzmán and M. Moya-Cabrera, Inorg. Chem., 2013, 52, 2793–2795 CrossRef PubMed.
  42. H. Zhu, J. Chai, H. W. Roesky, M. Noltemeyer, H. Schmidt, D. Vidovic and J. Magull, Eur. J. Inorg. Chem., 2003, 2003, 3113–3119 CrossRef.
  43. M. Dehmel, A. Köhler, H. Görls and R. Kretschmer, Dalton Trans., 2021, 50, 8434–8445 RSC.
  44. S. González-Gallardo, V. Jancik, D. G. Díaz-Gómez, F. Cortés-Guzmán, U. Hernández-Balderas and M. Moya-Cabrera, Dalton Trans., 2019, 48, 5595–5603 RSC.
  45. F. M. Mück, K. Junold, J. A. Baus, C. Burschka and R. Tacke, Eur. J. Inorg. Chem., 2013, 2013, 5821–5825 CrossRef.
  46. Y. Xiong, S. Yao, A. Kostenko and M. Driess, Dalton Trans., 2018, 47, 2152–2155 RSC.
  47. S. Takahashi, J. Sekiguchi, A. Ishii and N. Nakata, Angew. Chem., Int. Ed., 2021, 60, 4055–4059 CrossRef CAS PubMed.
  48. P. Garg, D. Dange and C. Jones, Eur. J. Inorg. Chem., 2020, 2020, 4037–4044 CrossRef CAS.
  49. S. Takahashi, A. Ishii and N. Nakata, Chem. Commun., 2021, 57, 6728–6731 RSC.
  50. B. Blom, M. Pohl, G. Tan, D. Gallego and M. Driess, Organometallics, 2014, 33, 5272–5282 CrossRef CAS.
  51. M. Veith, J. Frères, V. Huch and M. Zimmer, Organometallics, 2006, 25, 1875–1880 CrossRef CAS.
  52. A. G. Blackman, E. B. Schenk, R. E. Jelley, E. H. Krenske and L. R. Gahan, Dalton Trans., 2020, 49, 14798–14806 RSC.
  53. A. A. Ali, V. Huch, C. Aktas and M. Veith, Z. Anorg. Allg. Chem., 2016, 642, 973–978 CrossRef CAS.
  54. L. Yang, D. R. Powell and R. P. Houser, Dalton Trans., 2007, 955–964 RSC.
  55. M. Stender, B. E. Eichler, N. J. Hardman, P. P. Power, J. Prust, M. Noltemeyer and H. W. Roesky, Inorg. Chem., 2001, 40, 2794–2799 CrossRef CAS PubMed.
  56. M. E. Desat and R. Kretschmer, Inorg. Chem., 2019, 58, 16302–16311 CrossRef CAS PubMed.
  57. M. S. Hill, P. B. Hitchcock and S. M. A. Karagouni, J. Organomet. Chem., 2004, 689, 722–730 CrossRef CAS.
  58. X. Liu, H. Xia, W. Gao, L. Ye, Y. Mu, Q. Su and Y. Ren, Eur. J. Inorg. Chem., 2006, 2006, 1216–1222 CrossRef.
  59. B. E. Cole, J. P. Wolbach, W. G. Dougherty, N. A. Piro, W. S. Kassel and C. R. Graves, Inorg. Chem., 2014, 53, 3899–3906 CrossRef CAS PubMed.
  60. Y. Cheng, D. J. Doyle, P. B. Hitchcock and M. F. Lappert, Dalton Trans., 2006, 4449–4460 RSC.
  61. S. Dagorne, S. Bellemin-Laponnaz and R. Welter, Organometallics, 2004, 23, 3053–3061 CrossRef CAS.
  62. S. Sinhababu, R. K. Siwatch, G. Mukherjee, G. Rajaraman and S. Nagendran, Inorg. Chem., 2012, 51, 9240–9248 CrossRef CAS PubMed.
  63. (a) CCDC 2532228: Experimental Crystal Structure Determination, 2026,  DOI:10.5517/ccdc.csd.cc2qzzsh; (b) CCDC 2532229: Experimental Crystal Structure Determination, 2026,  DOI:10.5517/ccdc.csd.cc2qzztj; (c) CCDC 2532230: Experimental Crystal Structure Determination, 2026,  DOI:10.5517/ccdc.csd.cc2qzzvk; (d) CCDC 2532231: Experimental Crystal Structure Determination, 2026,  DOI:10.5517/ccdc.csd.cc2qzzwl; (e) CCDC 2532232: Experimental Crystal Structure Determination, 2026,  DOI:10.5517/ccdc.csd.cc2qzzxm; (f) CCDC 2532233: Experimental Crystal Structure Determination, 2026,  DOI:10.5517/ccdc.csd.cc2qzzyn; (g) CCDC 2538185: Experimental Crystal Structure Determination, 2026,  DOI:10.5517/ccdc.csd.cc2r65y3.

This journal is © The Royal Society of Chemistry 2026
Click here to see how this site uses Cookies. View our privacy policy here.